International Journal of Cardiovascular ResearchISSN: 2324-8602

Reach Us +1 850 900 2634
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

The Ability of Elevated Troponin I Values following Cardiac Surgery to Predict 30-Day and Long Term MajorAdverse Cardiovascular Events: A Single Center Experience

Background: The association between elevated troponin levels after coronary artery bypass grafting (CABG) surgery and short term all-cause mortality as well as major adverse cardiovascular events (MACE) is well documented. However, there is paucity of data reported on long term outcomes. Methods: Baseline patient characteristics, perioperative characteristics, and cardiac biomarkers within 24 hours were evaluated prospectively in a consecutive cohort of 419 subjects who underwent cardiac surgery in a single center, from 1 July 2002 through 30March 2007. Death, myocardial infarction, stroke, target vessel revascularization, and composite MACE were abstracted over a median follow-up of 16.8 months. Results: Troponin I values above 4.13 ng/mL were associated with a 45% increased risk for composite MACE (HR 1.45, 95%CI 1.023-2.067, p=0.038) over the first 2 years post cardiac surgery. Additionally, troponin I levels >4.13 n/mL were also associated with worse survival free from MACE (p=0.034). Troponin I values were not predictive of death, myocardial infarction, stroke or target vessel revascularization nor associated with survival free from these events. Multiple pre-, intra-, and periprocedural patient characteristics were associated with increased observed MACE rates to include preoperative ejection fraction <40%, chronic kidney disease, reoperation, and increased cardiopulmonary bypass times. Only EF ≥ 40% was associated with lower observed MACE. Conclusion: A troponin I level above 4.13 ng/mL was associated with a 45% observed increase in composite MACE during the first 2 years following CS. This finding is hypothesis generating only and may suggest measurement of troponin I level 24hrs after the CS may provide valuable prognostic data.

Special Features

Full Text

View

Track Your Manuscript

Share This Page

Media Partners

Associations